scispace - formally typeset
D

Dario Kivelevitch

Researcher at Scott & White Hospital

Publications -  32
Citations -  1745

Dario Kivelevitch is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Psoriasis & Population. The author has an hindex of 15, co-authored 31 publications receiving 949 citations. Previous affiliations of Dario Kivelevitch include Baylor University Medical Center.

Papers
More filters
Journal ArticleDOI

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

TL;DR: The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.
Journal ArticleDOI

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

TL;DR: In this article, the authors address important clinical questions that arise in psoriasis management and care, providing recommendations on the basis of available evidence, and provide recommendations based on available evidence.
Journal ArticleDOI

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.

TL;DR: This guideline provides detailed discussion of efficacy and safety for the most commonly used medications, including methotrexate, cyclosporine, and acitretin, and provides recommendations to assist prescribers in initiating and managing patients on these treatments.
Journal ArticleDOI

Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis:

TL;DR: Secukinumab offers the potential for equal, or improved, therapeutic effects compared with other biologics, and is a valuable addition to the current antipsoriatic armamentarium.
Journal ArticleDOI

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.

TL;DR: This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old.